In an exclusive interview with Benzinga Cannabis,Aaron Bloom, an attorney and CEO ofDocMJ, a multistate cannabis clinic, delved into the legal steps for rescheduling cannabis to Schedule III in the Controlled Substances Act, the possibility of categorizing cannabis under different regulatory frameworks, and how these changes may bring both challenges and opportunities for informed investors.

"Many practices that are common in the cannabis industry today, will become illegal under a federally regulated cannabis framework," Bloom explained.

Bureaucratic Road Map For Rescheduling Cannabis

The DEA's decision to reschedule cannabis from Schedule I to Schedule III marks a significant...